EcoDrugPlus

Ribosomal Protein S7

Ensembl ID : ENSLACG00000007780
Gene Symbol: RPS7
3 Cross references
358 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSLACG00000011099
Gene Symbol: RPS9
2 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSLACG00000003016
Gene Symbol: RPSA
4 Cross references
521 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSLACG00000018411
Gene Symbol: RPLP0
4 Cross references
398 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSLACG00000012630
Gene Symbol: RPLP1
4 Cross references
376 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSLACG00000016029
Gene Symbol: SERPINC1
4 Cross references
201 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSLACG00000003875
Gene Symbol: SIGMAR1
4 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSLACG00000008014
Gene Symbol: SIRT1
3 Cross references
157 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSLACG00000002467
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSLACG00000008521
Gene Symbol: SCNN1A
4 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSLACG00000012126
Gene Symbol: SCNN1B
2 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSLACG00000011637
Gene Symbol: SCNN1G
4 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).